LAWRENCE R. EVANS - 29 Aug 2025 Form 4 Insider Report for DAVEY TREE EXPERT CO

Role
EVP & GM, Surgery Company
Signature
/s/Lawrence R. Evans, Christopher J. Bast by Power of Attorney
Issuer symbol
N/A
Transactions as of
29 Aug 2025
Net transactions value
+$54,969
Form type
4
Filing time
29 Aug 2025, 10:55:11 UTC
Previous filing
22 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EVANS LAWRENCE R EVP & GM, Surgery Company 1500 N MANTUA ST, KENT /s/Lawrence R. Evans, Christopher J. Bast by Power of Attorney 29 Aug 2025 0001927362

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction Common Stock Options Exercise $32,720 +4,000 +1.9% $8.18 214,599 29 Aug 2025 Direct
transaction Common Stock Options Exercise $26,400 +3,000 +1.4% $8.80 217,599 29 Aug 2025 Direct
transaction Common Stock Options Exercise $32,470 +3,400 +1.6% $9.55 220,999 29 Aug 2025 Direct
transaction Common Stock Options Exercise $38,296 +3,630 +1.6% $10.55 224,629 29 Aug 2025 Direct
transaction Common Stock Options Exercise $48,400 +4,000 +1.8% $12.10 228,629 29 Aug 2025 Direct
transaction Common Stock Options Exercise $68,712 +8,400 +3.7% $8.18 237,029 29 Aug 2025 Direct F1
transaction Common Stock Sale $68,722 -2,695 -1.1% $25.50 234,334 29 Aug 2025 Direct F1
transaction Common Stock Options Exercise $38,720 +4,400 +1.9% $8.80 238,734 29 Aug 2025 Direct F1
transaction Common Stock Sale $38,709 -1,518 -0.64% $25.50 237,216 29 Aug 2025 Direct F1
transaction Common Stock Options Exercise $82,493 +8,638 +3.6% $9.55 245,854 29 Aug 2025 Direct F1
transaction Common Stock Sale $82,442 -3,233 -1.3% $25.50 242,621 29 Aug 2025 Direct F1
transaction Common Stock Sale $123,369 -4,838 -2% $25.50 237,783 29 Aug 2025 Direct F2
holding Common Stock 37,536 29 Aug 2025 By 401KSOP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -4,000 -100% $0.000000 0 29 Aug 2025 Common Stock 4,000 $8.18 Direct F4
transaction Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -3,000 -100% $0.000000 0 29 Aug 2025 Common Stock 3,000 $8.80 Direct F5
transaction Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -3,400 -100% $0.000000 0 29 Aug 2025 Common Stock 3,400 $9.55 Direct F6
transaction Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -3,630 -100% $0.000000 0 29 Aug 2025 Common Stock 3,630 $10.55 Direct F7
transaction Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -4,000 -100% $0.000000 0 29 Aug 2025 Common Stock 4,000 $12.10 Direct F8
transaction Stock Appreciation Rights (2016) Options Exercise $0 -8,400 -100% $0.000000 0 29 Aug 2025 Common Stock 8,400 $8.18 Direct
transaction Stock Appreciation Rights (2017) Options Exercise $0 -4,400 -100% $0.000000 0 29 Aug 2025 Common Stock 4,400 $8.80 Direct
transaction Stock Appreciation Rights (2018) Options Exercise $0 -8,638 -100% $0.000000 0 29 Aug 2025 Common Stock 8,638 $9.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

LAWRENCE R. EVANS is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Exercise of SARs upon retirement.
F2 Payment of taxes in connection with SARs pay-out.
F3 This total reflects routine accumulation of 37,536.2717 common shares acquired through the Company's 401(K) benefit plan as of August 29, 2025, based on internal records.
F4 These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2017.
F5 These options become exercisable in 20% installments on each anniversary of the grant date beginning June 23, 2018.
F6 These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2019.
F7 These options become exercisable in 20% installments on each anniversary of the grant date beginning June 12, 2020.
F8 These options become exercisable in 20% installments on each anniversary of the grant date beginning June 17, 2021.